Sunnybrook Health Sciences Centre
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Sunnybrook Health Sciences Centre sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Sunnybrook Health Sciences Centre: 7 sponsored US clinical trials, 2 recruiting.
Sunnybrook Health Sciences Centre sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Antimicrobial, with 1 trials.
Upper-quartile sponsor footprint
Sunnybrook Health Sciences Centre sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
NCT05427370
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response
NCT04134780
The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial
NCT02261415
Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI
NCT05220501
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness
NCT03005145
Cytokine Removal by CRRT in Pediatric Sepsis
NCT00537693
A Study on the Use of a Brace Following Low Back Surgery
NCT00620399
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Therapeutic Areas
Where Sunnybrook Health Sciences Centre enrollment is open (later-stage tilt)
2 recruiting of 7 indexed (29% open); 4 completed (57%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Antimicrobial (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Sunnybrook Health Sciences Centre: open-pipeline peers nationwide
Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Sunnybrook Health Sciences Centre sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Alabama Physical Therapy & Acupuncture · 29% recruiting · 14 trials
- AlloSource · 29% recruiting · 7 trials
- Alnylam Pharmaceuticals · 29% recruiting · 49 trials
- Annovis Bio · 29% recruiting · 7 trials
Related
What to do with this Sunnybrook Health Sciences Centre page
7 registered trials is a research-attention snapshot, not an endorsement of Sunnybrook Health Sciences Centre or any single study.
- 2 of Sunnybrook Health Sciences Centre's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Antimicrobial is the condition Sunnybrook Health Sciences Centre studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Antimicrobial trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Sunnybrook Health Sciences Centre pipeline card: 7 registered trials from official public datasets.Report a data error.